Clinical Trial Update: Nexium RESPONSE Trial [Phase 4]

View source ↗

Summary

The Nexium RESPONSE trial, a Phase 4 study evaluating esomeprazole for gastroesophageal reflux disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Phase 4 | Status: COMPLETED